Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Research and development | 85M | 92M | 101M | 96M | 97M | 98M |
| Selling, general and administrative | 25M | 23M | 22M | 28M | 33M | 37M |
| Operating expenses | 109M | 115M | 124M | 124M | 130M | 134M |
| Operating income | −109M | −115M | −124M | −124M | −130M | −134M |
| Interest expense | — | — | — | — | — | 562,000 |
| Pre-tax income | −101M | — | — | −114M | — | — |
| Income tax | 7,000 | — | — | 169,000 | — | — |
| Net income | −101M | −106M | −115M | −114M | −120M | −123M |
| Earnings per share | −0.16 | −0.18 | −0.20 | −0.21 | −0.23 | −0.25 |
| Earnings per share, diluted | −0.16 | −0.18 | −0.20 | −0.21 | −0.23 | −0.25 |
| Weighted average shares | 611M | 589M | 562M | 548M | 509M | 501M |
| Weighted average shares, diluted | 611M | 589M | 562M | 548M | 509M | 501M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 145M | 231M | 226M | 172M | 154M | 141M | 175M | 196M |
| Short-term investments | 760M | 740M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −60M | — | — | −61M | — | — |
| Depreciation and amortisation | 15M | 14M | 20M | 18M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 778M |
| 625M |
| 707M |
| 770M |
| 666M |
| 741M |
| Current assets | 916M | 982M | 1.02B | 806M | 871M | 922M | 854M | 973M |
| Property, plant and equipment | 240M | 251M | 250M | 266M | 289M | 300M | 318M | 322M |
| Total assets | 1.23B | 1.31B | 1.34B | 1.17B | 1.26B | 1.32B | 1.27B | 1.40B |
| Current liabilities | 44M | 62M | 48M | 49M | 52M | 65M | 61M | 112M |
| Total liabilities | 119M | 139M | 127M | 144M | 150M | 165M | 161M | 215M |
| Equity | 1.11B | 1.17B | 1.22B | 1.02B | 1.11B | 1.16B | 1.11B | 1.18B |
| 15M |
| 13M |
| Share-based compensation | 31M | 29M | 26M | 41M | 43M | 48M |
| Capital expenditure | 10M | — | — | 6M | — | — |
| Investing cash flow | −26M | — | — | 62M | — | — |
| Financing cash flow | −256,000 | — | — | 11M | — | — |